Michael Kleckner

This inventor holds 4 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Convergent R.n.r Ltd.. Active years: 2022-2024.

USPTO Granted Patents = 4 (Patent Applications = 1)

% Patents Active = 100.0

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 4.4

ph-index = 1

Location History:

Ramat-Ishai, IL (2022)
Ramat-Yishai, IL (2024)

Company Filing History:

3 out of 8

Convergent R.n.r Ltd.

patents

where one patent can have more than one assignee

Years Active: 2022-2024

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12109439 - Method of estimating dosimetric characteristics X-ray convergent irradiator to object to be irradiated (2024-10-08),

2. 11972875 - X-ray optical arrangement (2024-04-30),

3. 11364392 - Method of evaluating a dose as function of depth for nonuniform X-ray beams (2022-06-21),

4. 11250968 - Constructions of x-ray lenses for converging x-rays (2022-02-15),

Title: Michael Kleckner: Innovator in Radiotherapy Technologies

Introduction

Michael Kleckner is a notable inventor based in Ramat Ishai, Israel. He has made significant contributions to the field of radiotherapy through his innovative patents. With a total of 4 patents, Kleckner's work focuses on enhancing the precision and effectiveness of X-ray treatments.

Latest Patents

Kleckner's latest patents include a method for estimating dosimetric characteristics of an X-ray convergent irradiator. This method involves several steps, including providing a converging X-ray beam source and directing the beam towards a volume of treatment within a patient's body. The technique ensures that the maximum dose is effectively delivered to the targeted area while minimizing exposure to surrounding tissues. Another significant patent involves the manufacturing of burr-edged reflecting tile elements for a mosaic X-ray lens. This method utilizes a single crystal to create precise reflecting surfaces that enhance the quality of the X-ray beam.

Career Highlights

Michael Kleckner is currently associated with Convergent R.N.R. Ltd., where he continues to develop innovative solutions in the field of radiotherapy. His expertise in X-ray technology has positioned him as a key figure in advancing treatment methodologies.

Collaborations

Kleckner collaborates with talented professionals such as Shirly Borukhin and Aharon Bar-David. Their combined efforts contribute to the ongoing development of cutting-edge technologies in radiotherapy.

Conclusion

Michael Kleckner's contributions to radiotherapy through his innovative patents demonstrate his commitment to improving patient care. His work continues to influence the field and pave the way for future advancements in medical technology.